Literature DB >> 21925470

High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils.

Estibaliz Capetillo-Zarate1, Luis Gracia, Fangmin Yu, Jason R Banfelder, Michael T Lin, Davide Tampellini, Gunnar K Gouras.   

Abstract

β-Amyloid (Aβ) accumulation and aggregation are hallmarks of Alzheimer's disease (AD). High-resolution three-dimensional (HR-3D) volumetric imaging allows for better analysis of fluorescence confocal microscopy and 3D visualization of Aβ pathology in brain. Early intraneuronal Aβ pathology was studied in AD transgenic mouse brains by HR-3D volumetric imaging. To better visualize and analyze the development of Aβ pathology, thioflavin S staining and immunofluorescence using antibodies against Aβ, fibrillar Aβ, and structural and synaptic neuronal proteins were performed in the brain tissue of Tg19959, wild-type, and Tg19959-YFP mice at different ages. Images obtained by confocal microscopy were reconstructed into three-dimensional volumetric datasets. Such volumetric imaging of CA1 hippocampus of AD transgenic mice showed intraneuronal onset of Aβ42 accumulation and fibrillization within cell bodies, neurites, and synapses before plaque formation. Notably, early fibrillar Aβ was evident within individual synaptic compartments, where it was associated with abnormal morphology. In dendrites, increasing intraneuronal thioflavin S correlated with decreases in neurofilament marker SMI32. Fibrillar Aβ aggregates could be seen piercing the cell membrane. These data support that Aβ fibrillization begins within AD vulnerable neurons, leading to disruption of cytoarchitecture and degeneration of spines and neurites. Thus, HR-3D volumetric image analysis allows for better visualization of intraneuronal Aβ pathology and provides new insights into plaque formation in AD.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925470      PMCID: PMC3204026          DOI: 10.1016/j.ajpath.2011.07.045

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Intraneuronal Abeta42 accumulation in human brain.

Authors:  G K Gouras; J Tsai; J Naslund; B Vincent; M Edgar; F Checler; J P Greenfield; V Haroutunian; J D Buxbaum; H Xu; P Greengard; N R Relkin
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.

Authors:  Anne M Cataldo; Suzana Petanceska; Nicole B Terio; Corrinne M Peterhoff; Robert Durham; Marc Mercken; Pankaj D Mehta; Joseph Buxbaum; Vahram Haroutunian; Ralph A Nixon
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

3.  Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.

Authors:  Marlen Knobloch; Uwe Konietzko; Danielle C Krebs; Roger M Nitsch
Journal:  Neurobiol Aging       Date:  2006-07-31       Impact factor: 4.673

4.  Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.

Authors:  Judit España; Lydia Giménez-Llort; Jorge Valero; Alfredo Miñano; Alberto Rábano; José Rodriguez-Alvarez; Frank M LaFerla; Carlos A Saura
Journal:  Biol Psychiatry       Date:  2009-08-07       Impact factor: 13.382

5.  Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.

Authors:  M R D'Andrea; R G Nagele; H Y Wang; P A Peterson; D H Lee
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

6.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

7.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.

Authors:  Feng Li; Noel Y Calingasan; Fangmin Yu; William M Mauck; Marine Toidze; Claudia G Almeida; Reisuke H Takahashi; George A Carlson; M Flint Beal; Michael T Lin; Gunnar K Gouras
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

10.  Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice.

Authors:  Jin G Sheng; Susan H Bora; G Xu; David R Borchelt; Donald L Price; Vassilis E Koliatsos
Journal:  Neurobiol Dis       Date:  2003-10       Impact factor: 5.996

View more
  13 in total

1.  Critical role of intraneuronal Aβ in Alzheimer's disease: technical challenges in studying intracellular Aβ.

Authors:  Gunnar K Gouras; Katarina Willén; Davide Tampellini
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

2.  Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.

Authors:  Juciano Gasparotto; Carolina S Girardi; Nauana Somensi; Camila T Ribeiro; José C F Moreira; Monique Michels; Beatriz Sonai; Mariane Rocha; Amanda V Steckert; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Daniel P Gelain
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

3.  Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.

Authors:  Marta Rolland; Rebecca Powell; Muriel Jacquier-Sarlin; Sylvie Boisseau; Robin Reynaud-Dulaurier; Jose Martinez-Hernandez; Louise André; Eve Borel; Alain Buisson; Fabien Lanté
Journal:  J Neurosci       Date:  2020-05-22       Impact factor: 6.167

Review 4.  Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.

Authors:  Bianca Gonzalez; Edsel M Abud; Abigail M Abud; Wayne W Poon; Karen H Gylys
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 5.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

6.  Direct observations of amyloid β self-assembly in live cells provide insights into differences in the kinetics of Aβ(1-40) and Aβ(1-42) aggregation.

Authors:  Elin K Esbjörner; Fiona Chan; Eric Rees; Miklos Erdelyi; Leila M Luheshi; Carlos W Bertoncini; Clemens F Kaminski; Christopher M Dobson; Gabriele S Kaminski Schierle
Journal:  Chem Biol       Date:  2014-05-22

7.  Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.

Authors:  O Klementieva; K Willén; I Martinsson; B Israelsson; A Engdahl; J Cladera; P Uvdal; G K Gouras
Journal:  Nat Commun       Date:  2017-03-13       Impact factor: 14.919

8.  Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.

Authors:  Reisuke H Takahashi; Estibaliz Capetillo-Zarate; Michael T Lin; Teresa A Milner; Gunnar K Gouras
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 9.  Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases.

Authors:  Gunnar K Gouras
Journal:  Int J Cell Biol       Date:  2013-11-07

Review 10.  Peptides as Potential Therapeutics for Alzheimer's Disease.

Authors:  Samo Ribarič
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.